PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
18-Nov-2024 Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets AccessWire
18-Nov-2024 Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis AccessWire
18-Nov-2024 Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease AccessWire
18-Nov-2024 NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders AccessWire
18-Nov-2024 Iqirvo® (elafibranor) data show efficacy and tolerability for up to 3 years in patients with PBC with improvements in fatigue and pruritus Ipsen
18-Nov-2024 Interactive Strength Inc. (Nasdaq:TRNR) Expands CLMBR’s Presence with Military and College Accounts by Exhibiting at the Athletic Business Show on November 19-22 AccessWire
18-Nov-2024 Quell Therapeutics Achieves Milestone for Type 1 Diabetes CAR-Treg Cell Therapy Program Quell Therapeutics
18-Nov-2024 Cure51 launches NHS-approved study with Cambridge University Hospitals and seven other leading UK oncology institutions to unlock cancer survival secrets Cure51
18-Nov-2024 BrightHeart Secures FDA Clearance for First AI Software Revolutionizing Prenatal Fetal Heart Ultrasound Evaluations BrightHeart
18-Nov-2024 ICR Healthcare and Sponsors Host 12th Annual Healthcare Conference: Development, Deals and Dollars ICR Healthcare
18-Nov-2024 Update on Financial Position Celadon Pharmaceuticals Plc
18-Nov-2024 The King’s Fund calls on NHS leaders to help unlock power of industry partnerships ABPI
18-Nov-2024 iiCON funds 11 new innovative projects focused on tackling infectious diseases iiCON
18-Nov-2024 UK Regulator MHRA Grants Nanomerics Clinical Trials Authorisation Notice for its Upcoming OC134 Clinical Trial AccessWire
18-Nov-2024 Formycon receives positive CHMP opinion for FYB203 (aflibercept), a biosimilar candidate to Eylea® under the tradenames AHZANTIVE® and Baiama® Formycon AG
18-Nov-2024 Better Mental Healthcare Outcomes for Implementing Patient-Engaging Solutions Research Nester
18-Nov-2024 Proregulations Launches U.S. Drug Master File Document Production and Filing Service Proregulations
18-Nov-2024 Protheragen-ING Announces Lyophilized Flash-release Formulations Development Capabilities Protheragen-ING
18-Nov-2024 Protheragen-ING AI-Pharma’s AI-Powered Drug Discovery and Design Platform—A Paradigm Shift in Drug Development Protheragen-ING
18-Nov-2024 Hometown NP Expands Telepsychiatry Services to 39 States Nationwide AccessWire